U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546045) titled 'Personalized Rehabilitation With Organ-Preserving Robotic RESA in Head & Neck Cancer' on March 31.
Brief Summary: This study aims to evaluate whether an intensive and personalized speech, swallowing, and voice rehabilitation (SSVR) program can help preserve swallowing function in patients with head and neck cancer undergoing minimally invasive robotic-assisted extended "Sistrunk" surgery (RESA).
Participants will undergo the RESA surgery as part of their standard care. After surgery, they will receive a structured SSVR program for 12 weeks, including daily exercises performed both with a speech therapist and independently. The pro...